Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs

• Published in: Journal of parasitology research 2019, Vol.2019 (2019), p.1-8
• Main Authors: Doumbo, Ogobara K., Thera, Mahamadou A., Laurens, Matthew B., Marty, P., Izri, Arezki, Piarroux, Martine, Niaré, Doumbo Safiatou, Kone, Abdoulaye K., Piarroux, Renaud
• Format: Article
• Language: English
• Subjects: Leishmania; Microscope and microscopy; Review
• ISSN: 2090-0023; 2090-0031
• DOI: 10.1155/2019/9282690

Visceral leishmaniasis (VL) is the most serious form of human leishmaniasis. VL is understudied in West Africa. The increasing number of patients at-risk, including persons living with HIV and other chronic immunosuppressive diseases, and likely underreporting of VL related to diagnostic challenges advocate for review of existing data to understand VL regional epidemiology. Our review aims to describe the clinical characteristics and epidemiology of Human VL (HVL) in West Africa. We conducted a literature search to identify peer-reviewed articles and grey literature sources using the search terms “Visceral leishmaniasis West Africa”, “Leishmania donovani West Africa”; and “Leishmania infantum West Africa”. Thirty published articles report HVL from seven countries, including The Gambia, Niger, Nigeria, Ivory Coast, Togo, Burkina Faso, and Guinea Bissau. Three countries report cases of Canine Visceral Leishmaniasis (CVL), including The Gambia, Senegal, and Burkina Faso. Niger, Nigeria, and Ivory Coast report the greatest number of HVL cases. As VL is present in West Africa, active surveillance, increased diagnostic capacity, and studies of vectors and reservoirs are essential to better understand VL epidemiology in the region.